Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2003
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1367888A2 Selective substituted aryl ketone and safener based herbicides
12/10/2003EP1129120B1 Modified polyisocyanates
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/09/2003US6660885 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/09/2003CA2123697C Novel substituted salicylic acids
12/09/2003CA2100637C Process for the production of 2-substituted-5-chlorimidazole-4-carbaldehydes
12/09/2003CA2053716C Pesticidal 1-arylimidazoles
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003074550A3 Pin1-modulating compounds and methods of use thereof
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2003027130A3 Transition metal complexes for preparing olefin oligomers
12/04/2003US20030225288 Small organic compounds to modulate chemokine receptor activity; treating psoriasis, autoimmune diseases, multiple sclerosis, graft rejection, infectious diseases; anti-allergen, -arthritic, -inflammatory, carcinogenic agents
12/04/2003US20030225287 Synthesis of chiral 2-alkyl amino acids
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225149 Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225064 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030224006 A solid phase that is sustained by intermolecular interactions (hydrogen bonding) between two or more independent molecular entities, and at least one entity is a drug; improved drug solublity, stability, bioavailability
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1366816A1 Organometallic complexes containing N-hetereocycle and alcohol bidentate chelating ligands, and their use for olefin oligomerisation
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/03/2003EP1366025A1 Agonists of beta-adrenoceptors
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003EP1366017A2 Non-natural basic amino acids, their preparation and use
12/03/2003EP1366016A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/03/2003EP0786455B1 Imidazole derivative
12/03/2003EP0693072B1 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/03/2003CN1129581C Cyanophenyl derivatives
12/03/2003CN1129468C Alkylated ammonia alkyl cyclic urea surface active agent
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
12/02/2003CA2246909C Method for chemical synthesis of oligonucleotides
11/2003
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097611A1 Novel imidazole compounds, method for preparing same and use thereof as medicines
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003097587A2 Gelling agents
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003076366A3 A method for preparing organic fluorocompounds
11/27/2003WO2003062249A3 Coordination complex
11/27/2003WO2003048078A3 Production of ionic liquids
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220508 An enzyme inhibitor for treating AIDS, viral infections
11/27/2003US20030220507 Enantioselective transformation of alpha,beta-unsaturated ketones using chiral organic catalysts
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
11/27/2003US20030220495 Inhibitors of farnesyl protein transferase
11/27/2003US20030220469 Novel compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same
11/27/2003US20030220415 Heterocyclic amine diol compounds and their biocidal derivatives
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220352 Benzylated PDE4 inhibitors
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030219893 Compositions and methods for the treatment of hepatitis C virus infection
11/27/2003US20030219879 Method for producing D-allo -isoleucine
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/26/2003EP1364985A1 Water-absorbent resin, process for production thereof, and water-absorbent resin composition
11/26/2003EP1364958A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof
11/26/2003EP1364957A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof
11/26/2003EP1364941A1 Gelling agents
11/26/2003EP1363911A1 Synthesis of temozolomide and analogs
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363890A2 Melanocortin-4 receptor binding compounds and methods of use thereof
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363509A1 Compositions containing creatine and creatinine
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653086 Fusion protein; ligand has not been identified; screening for agonists/ antagonists
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003CA2117305C Substituted imidazole derivatives and their preparation and use
11/25/2003CA2105014C Imidazolidine derivatives
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 345